AbelZeta Pharma
1 known investors
AbelZeta develops T cell immunotherapies, advancing pipeline drug candidates through early-stage and investigator-initiated clinical trials to treat cancer and immune and inflammatory (I&I) diseases. The company runs an in-house platform for cell therapy development and partners with global pharmaceutical firms for clinical development and commercialization.
Investors · 1
Frequently asked questions
- What does AbelZeta Pharma do?
- AbelZeta develops T cell immunotherapies, advancing pipeline drug candidates through early-stage and investigator-initiated clinical trials to treat cancer and immune and inflammatory (I&I) diseases. The company runs an in-house platform for cell therapy development and partners with global pharmaceutical firms for clinical development and commercialization.
- Who are AbelZeta Pharma's investors?
- AbelZeta Pharma's investors include HongShan Capital Group.